We are excited to announce the launch of Viewics Diabetes Management (vCAT)™, a free solution that enables clinical laboratories to provide value-based healthcare organizations with analytics that directly support management of diabetic populations. This is the first product launched in our new Catapult™ product line, which aims to deliver analytics capabilities to health systems without investment or IT involvement.
In the shifting value-based marketplace, healthcare organizations need to be able to effectively analyze their performance on diabetes quality measures, but often lack the tools to do so. At the same time, laboratories are challenged to increase and optimize their offerings to demonstrate their value to healthcare executives. Viewics Diabetes Management (vCAT) creates an opportunity for laboratories to provide clinicians and health executives with actionable analytics as a value-added service.
“It is critical for laboratories to provide evidence of economic contribution in accountable care and other alternative payment model settings,” said Dr. Eleanor Herriman, Chief Medical Informatics Officer at Viewics. “Offering these analytics elevates the value laboratories provide, setting them apart from their competitors in the market.”